Elizabeth M. Troll is a seasoned executive with over 42 years of global leadership in quality assurance, regulatory compliance, and governance within the pharmaceutical, biopharmaceutical, and healthcare industries. Renowned for her expertise in Quality Management Systems (QMS), vendor oversight, inspection readiness, and leadership development, Liz has played a pivotal role in shaping compliance frameworks that align regulatory standards with business efficiency. She has led quality and compliance initiatives at Endpoint Clinical, Novan Inc., QuintilesIMS, and Otsuka, driving strategic improvements and fostering a culture of operational excellence. A dynamic speaker and mentor, Liz is passionate about developing future leaders, advancing industry best practices, and supporting organizations in achieving regulatory success. With a strong commitment to integrity, respect, and continuous improvement, she seeks to leverage her expertise through board service and advisory roles, helping companies navigate complex regulatory landscapes and drive sustainable growth.

Aparna Srinivasan is a seasoned technology executive and product strategist with over 25 years of experience driving innovation, business growth, and digital transformation across Fortune 500 companies and high-growth startups. With expertise in digital commerce, AI/ML, blockchain, and financial risk analysis, she has successfully led product initiatives generating over $500 million in annual recurring revenue. A visionary leader, Aparna has reported to the C-suite, presented to board members, and co-owned P&L responsibilities, demonstrating her ability to scale businesses, develop market-leading strategies, and foster high-performing teams. Passionate about mentoring women in technology and advocating for STEM education, she is actively seeking board opportunities where she can leverage her expertise in product innovation, financial strategy, and executive leadership to drive meaningful impact.